INVITATION TO SUBSCRIBE FOR SHARES IN BPC INSTRUMENTS AB
IMPORTANT INFORMATION
Any investment in securities is associated with risk. The memorandum for BPC Instruments AB (“BPC Instruments” or the “Company”) outlines potential risks relating to the Company’s operations and its securities. Before making an investment decision, the information about these risks, together with the rest of the memorandum, should be read carefully. The memorandum is available to download from the Company’s website (www.bpcinstruments.com), Sedermera Fondkommission’s website (www.sedermera.se) and Spotlight Stock Market’s website (www.spotlightstockmarket.se).
Excellence is
built on precision
and accuracy
”The solutions of BPC
Instruments are the first of their kind, making the Company a pioneer in its field.”
A WORLD-LEADING COMPANY
BPC Instruments offers world-leading instruments for measuring ultra-low gas volume and flow rate. Many biotechnological processes such as biogas production are performed by microorganisms. The triggering catalyst is determined when the activity of the microbes performing the reaction changes.
BPC Instruments develops and sells automated analytical apparatuses that analyses these reactions. The Company is a pioneer in its field, and the Board of Directors estimates that the Company’s current share of the global market of feedstock quality analysis in biogas production equals approx. 90 percent.
BPC Instruments has recently expanded towards the business fields of biodegradability of plastics and in-vitro feed analysis for animal farming and aims to expand from a single niche market to multiple biotech industrial markets and have a substantial first-mover advantage.
BASED ON CUTTING EDGE RESEARCH
The Company was founded in 2005 and brings about 20 years of industry-leading research in the areas of instrumentation, control, and automation of anaerobic digestion processes.
Staffed by experienced scientists and engineers, BPC Instruments exports to more than 60 countries.
FLOURISHING EXISTING REVENUE
In 2021, BPC Instruments expects to receive net sales revenue amounting to approx. SEK 24 million, with an estimated net profit of SEK 4 million. These stable existing revenues, with a customer base in over 60 countries, provide a solid foundation for business growth as the Company intends to expand into multiple biotech industrial sectors. BPC Instruments is a company interested in long-term solid business growth based on cleantech and sustainability.
WHY INVEST IN BPC INSTRUMENTS?
RAPID GROWTH
BPC Instruments intends to expand rapidly in the upcoming years, and the Company’s financial objective is to increase net sales revenue by double digits annually over the next three years and beyond. This will be achieved through launching new products, broadening the Company’s offer, and further strengthening the Company’s position in the EU, South Asia, and North America.
STRONG BOARD OF DIRECTORS
The Board of Directors of BPC Instruments has a proven track record of successfully running biotech companies. Board member Kristofer Cook has co-founded several award-winning companies in the biotechnology, cleantech, and food tech areas, including Bioextrax, Cyclicor, and Carbiotix. Board member and CEO Dr. Jing Liu has led the Company since 2013 and has been nominated for several research and enterprise awards. He has a vast background in business and technical development in the biotechnology and biogas industry.
A CLEANTECH INVESTMENT
BPC Instruments’ business development activities, with a core competence and focus on clean technologies, renewable resources, sustainability, and innovation in biotechnology analysis, perfectly matches with global business trends. BPC Instruments’ products make a positive difference – for the Company’s customers as well as for the climate.
Gas Endeavour®